Patients with Crohn’s Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability
Crossref DOI link: https://doi.org/10.1007/s10620-015-3618-8
Published Online: 2015-03-14
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shah, Eric D.
Siegel, Corey A.
Chong, Kelly
Melmed, Gil Y.
Text and Data Mining valid from 2015-03-14